Research Reports
Automated CPR Devices Market: Growing demand for better products is expected to drive the market
Cardiopulmonary resuscitation (CPR) is an emergency and lifesaving technique consists of chest compression and artificial ventilation. CPR is performed to maintain the blood flow and oxygenation to brain in case of cardiac arrest. CPR main function is to maintain partial flow of oxygenated blood to brain and heart. The main purpose is to delay tissue death to achieve successful resuscitation and protecting brain from permanent damage
The automated CPR devices market is anticipated to grow rapidly with a 11% CAGR in the period of assessment between 2015 and 2025.Fears over the spread of coronavirus spread with the practice of conventional CPR procedures, has increased the popularity of automated CPR devices to treat patients during the crisis period. In addition, the higher mortality rate of coronavirus patients also supports the production and sales of such devices in the short term.
The inclining cases of sudden cardiac arrests across the globe may serve as growth generators for the automated CPR devices market across the forecast period of 2015-2025. A CPR device is used for chest compression. These devices help to deliver consistent and high-frequency compressions across the cardiac arrest phase. These devices are more efficient than manual CPR devices in terms of performance. Therefore, the efficacy factor may turn out to be the trump card of growth for the automated CPR devices market.
“Conventional chest compressions are often ineffective owing to longer pauses between compressions, which hurts survival rates. Automated CPR devices solve these issues by automating chest compression rates, which is more likely to improve patient outcomes, bolstering demand through and after the pandemic,” states the FMI analyst.
Download a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-720
Automated CPR Devices Market- Critical Takeaways
- Battery run automated CPR devices are rapidly gaining traction owing to smaller size and easier portability.
- LUCAS pneumatic automated CPR devices are gaining interest, owing to higher customization in operations.
- North America followed by Europe are leading automated CPR device markets, supported by easier access to new medical tech, and higher investment into healthcare infrastructure.
Classification of CPR devices
- Pneumatic driven
- Thumper
- LUCAS
- Battery driven
- AutoPulse
Effective CPR can improve the survival rate of patients with cardiac arrest. It has been found that the quality of CPR performed by healthcare professionals in hospital and out of the hospital is poor. Assessment of CPR practices by medical professionals revealed that chest compressions are few and ineffective and have significant pauses during compression that results in decrease of survival rate. Automated CPR devices have overcome these drawbacks by the use of mechanical automated chest compression device, which may lead to improve perfusion pressures by overcoming the drawbacks of conventional manual CPR. Clinical and laboratory studies have shown, blood pressure level getting normal with automatic chest compression devices and enhanced neurological outcomes following extended cardiac arrest. According to American Heart Association, around 92 percent victims of sudden cardiac arrest die before reaching to hospital. According to statistics it has been proved if more people are aware of CPR, more lives could be saved.
Automated CPR Devices Market- Drivers
- Superior performance in terms of coronary perfusion and hemodynamics bolsters adoption of automated CPR devices.
- Increasing awareness among public about the risks of cardiac arrests and the availability of CPR devices aids market growth.
- Higher rates of hospitalization for cardiac ailments helps sales and revenue.
Automated CPR Devices Market- Restraints
- Lack of adequate professionals with requisite training hinders market growth.
- High costs of purchasing automated CPR devices holds back adoption rates.
For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-720
Coronavirus Impact on Automated CPR Devices Market
The coronavirus outbreak has resulted in substantial increase in the demand for automated CPR devices. The high mortality rate of the disease, coupled with fear of viral contagion through conventional CPR procedures bolsters market growth. Further, manufacturers are focusing on optimizing supply chains for the pandemic, to reduce the gap between supply and demand during the crisis period.
Competitive Landscape
Manufacturers in the automated CPR devices market are largely focused on product development efforts. For instance, Cintas has revealed a novel automated CPR device, which provides medical practitioners with real time CPR feedback for superior patient outcomes.
SunLife Science Inc., ZOLL Medical Corporation, Michigan Instruments, Physio Control Inc., and Brunswick Biomedical Technologies are some of the leading automated CPR device manufacturers.
Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/customization-available/rep-gb-720
About the Study
The study offers readers a comprehensive assessment of the automated CPR device market. Global, regional and national-level analysis of the latest trends influencing the automated CPR device market is covered in this FMI report. The study provides insights according to type (pneumatic and battery-powered), in five regions (North America, Latin America, Europe, Asia Pacific and MEA).
-
Business3 days ago
Mike Bahun and Fundraising University Make a Lasting Impact on Sports Programs Nationwide
-
Top Stories4 days ago
After VW plant victory, UAW sets its sights on Mercedes in Alabama
-
Investing3 days ago
Forex Market Trends to Watch Out For in 2024
-
Top Stories4 days ago
Hedge fund borrowing hits five-year peak, Goldman Sachs says